Sponsored by:
Gastroenterology Grand Rounds
Academic Year 2013-2014
GASTROENTEROLOGY GRAND ROUNDS
February 26, 2014
5:30 pm – 6:30 pm
9 Penn Tower
KIMBERLY FORDE, MD, MHS
Assistant Professor of Medicine & Epidemiology
Senior Scholar, CCEB
and
DAVID KAPLAN, MD, MSC
Assistant Professor of Medicine
Director, HCC Program Philadelphia VA Medical Center
Co-Director, Frontiers in Gastroenterology Course
University of Pennsylvania Perelman School of Medicine
Division of Gastroenterology
“Bench to Bedside:
A Jaundiced Perspective on Cirrhosis-Related Infections”
Target Audience
This program has been designed for departmental/institutional faculty, fellows, residents, medical students, and community
physicians in the medical specialties of internal medicine, gastroenterology, pediatric gastroenterology, and pediatrics.
Educational Objectives
After completing this activity, participants should be able to:
 Review pathophysiology of a broad variety of complex gastrointestinal problems and disorders
 Describe the most recent treatment for a broad spectrum of GI diseases
 Manage diagnostic testing in an appropriate manner for a variety of gastrointestinal diseases
 Improve effective communication skills
 Apply evidence from the current literature and incorporate new strategies, techniques and therapies in patient care
Accreditation
The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA PRA
Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acknowledgement of Commercial Support*
NONE
For more information, please contact
Michele Fitzpatrick
215-898-0154
mfitzp@mail.med.upenn.edu
Check your CME online at www.penncmeonline.com
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at the Perelman School of Medicine at the University of Pennsylvania for individuals who are in a position to control the
content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial
interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this
purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in
CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice,
are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all
content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to
contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were
instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, Director of
CME and the peer reviewer Zalman Agus, MD, Associate Dean for CME, have disclosed that they have no relevant financial
relationships with any commercial interests related to the content of this educational activity.
The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to
the content of this educational activity:
PLANNING COMMITTEE MEMBER NAME
ANIL RUSTGI, MD
PRESENTER NAME
Kimberly Forde, MD, MHS
The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of
this educational activity.
PLANNING COMMITTEE MEMBER NAME
NAME OF COMMERCIAL INTEREST
RELATIONSHIP
GARY R. LICHTENSTEIN, MD
ABBOTT CORP/ ABBVIE, ELAN, HOSPIRA, MILLENIUM PHARMA
CONSULTANT
ONO PHARMA, PFIZER PHARMA, SANTARUS, SCHERING-PLOUGH CORP, TAKEDA
CONSULTANT
ALAVEN, JANSSEN ORTHOBIOTECH, FERRING, PROMETHEUS LAB INC
CONSULTANT, RESEARCH
SALIX PHARMA, SHIRE PHARMA, UCB, WARNER CHILCOTTE
CONSULTANT, RESEARCH
BRISTOL MYERS SQUIBB
RESEARCH
IRONWOOD
HONORARIUM
DAVID C. METZ, MD
EISAI
DMSB
NOVARTIS
CONSULTANT
TAKEDA
SPEAKER
AAA, IPSEN
PROTOCOL
PRESENTER NAME
David Kaplan, MD, MSC
NAME OF COMMERCIAL INTEREST
RELATIONSHIP
Bayer
Co-Principal Investigator
Merck
Principal Investigator
Relevant Financial Relationships: Financial relationships are those relationships in which the individual benefits by receiving a salary,
royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership
interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as
employment, management position, independent contractor (including contracted research), consulting, speaking and teaching,
membership on advisory committees or review panels, board membership, and other activities from which remuneration is received
or expected.
DISCLOSURE OF UNAPPROVED USES OF PRODUCTS
PRESENTER NAME
PRODUCT
INVESTIGATIONAL AND/OR OFF-LABEL USES